MENU
Language Switcher
Web予約できます 診療予約
沖縄市の総合的ライフスタイル提案する心不全、生活習慣病クリニック　
Language Switcher
  1. ホーム
  2. Physician

Physician

Satoshi Yamaguchi

Since 2011, Dr. Yamaguchi has been working in Okinawa as a cardiologist. He spent two years from 2016 at Cedars-Sinai Medical Center in the U.S. to conduct echocardiography research. Since 2019, He was working at Nakagami Hospital. His specialty is ischemic heart disease (myocardial infarction and angina pectoris). Over 100 percutaneous coronary interventions, he performs annually.
He is also researching clinical research on heart failure, biomarkers, and echocardiography.

Carrier

-2004Dokkyo University, School of Medicine
2004-2006Kameda Medical Center, Junior Residency Program
2006-2010Kameda Medical Center, Department of Anesthesiology
2011Tomishiro Central Hospital, Internal Medicine Fellowship
2012-2016Tomishiro Central Hospital, Deparatment of Cardiology
2016-2018Cedars-Sinai Medical Center, Heart Institute
2019Nakagami Hospital, Department of Cardiology
2019-Fukushima Medical University,
Department of Diabetes, Endocrinology and Metabolism School of Medicine,
-2020University of the Ryukyus (Ph.D.)
2020-2023Nakagami Hospital, Department of Cardiology, Attending Physician

Certification

Doctor of Philosophy

Board Certified Member of the Japanese Society of Internal Medicine

Fellow of the Japanese Society of Internal Medicine (FJSIM)

Board Certified Member of The Japanese Circulation Society

Board Certified Member of Japanese Association of Cardiovascular Intervention and Therapeutics

Registered Instructor of Cardiac Rehabilitation (RICR)

Academic activities

Original articles

Yamaguchi, S., Shimabukuro, M., Tanaka, A., Imai, T., Hiramitsu, S., Takahashi, N., Kadokami, T., Ajioka, M., Suzuki, M., Node, K., & CANDLE Trial Investigators. (2022). Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial. Diabetes, Obesity & Metabolism. https://doi.org/10.1111/dom.14876

Nakayama, Y., Yamaguchi, S., Shinzato, Y., Okamoto, S., Millman, J. F., Yamashiro, K., Takemoto, N., Uema, T., Arakaki, K., Higa, M., Koizumi, H., Shimabukuro, M., & Masuzaki, H. (2021). Retrospective exploratory analyses on gender differences in determinants for incidence and progression of diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Endocrine Journal, 68(6), 655–669.

Yamaguchi, S., Oba, K., Higa, M., Arasaki, O., & Shimabukuro, M. (2020). Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus. Journal of Clinical Medicine Research, 9

Case reports

Yamaguchi, S., Nadoyama, N., Kinjo, K., Yagi, N., Ishimori, H., & Shimabukuro, M. (2023). The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension. Cureus, 15(6), e40609.

Yamaguchi, S., & Shimabukuro, M. (2022). Acute Myocardial Infarction During the Last Part of a Triathlon: A Case Report. Cureus, 14(12), e32768.

和文総説

山口 怜, 島袋 充生 (2021) チアゾリン薬と心不全. 糖尿病 内分泌代謝科, 52(3):242